Real-time enrollment status for this kras np_004976.2:p.g12d clinical trial
Current Status
Recruiting
Checked: September 5, 2026 at 6:26 AM UTC
| NCT Number | NCT03608631 |
| Recruiting Status | Recruiting |
| Condition | KRAS NP_004976.2:p.G12D |
| Phase | PHASE1 |
| Target Enrollment | 28 participants |
| Active Locations | 1 sites in the US |
| Sponsor | M.D. Anderson Cancer Center |
| Last Updated on CT.gov | September 4, 2026 (Yesterday) |
As of September 5, 2026: Clinical trial NCT03608631 is currently recruiting participants. This phase1 study for kras np_004976.2:p.g12d is actively seeking new participants at 1 location across the United States. The study is sponsored by M.D. Anderson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03608631 is actively recruiting participants as of September 5, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03608631 was last updated Yesterday (September 4, 2026). HelloStudys verifies this status automatically.